Moreover, the pooled HR estimate for OS of patients with NSCLC was 1.88 (95% CI: 1.30–2.73) in the analysis of the 2 studies with multivariate analysis, suggesting that p16 hypermethylation might be an independent prognostic factor for patients with NSCLC. This evidence concerns the gene CDKN2A and non-small cell lung carcinoma.